Filtrer
18 months EU-funded postdoctoral in Immunology
To study the immunogenicity of Pan-EBOLA vaccines and their mechanisms of action 07 Octobre 2018
Lieu Institute of Molecular and Cellular Pharmacology (IPMC)
Ville Nice, France
Type
Postdoc
Rémunération NC

The research group “Immune regulations at muco-cutaneous surfaces” headed by Drs Fabienne Anjuère and Véronique Braud is a member of the PEVIA EU project that aims to bring to clinics multivalent non live vaccines against EBOLA infection (2017-2022). This research group is hosted in the Institute of Molecular and Cellular Pharmacology (IPMC) (http://www.ipmc.cnrs.fr), located in Sophia-Antipolis/Nice, South-East area of France. IPMC is a leading Research Center of the Université Côte d’Azur equipped with state of the art core facilities and dynamic scientific environment.


Applications are invited for a full-time postdoctoral position in Immunology/Vaccinology (18 months) to participate to the development of a family of vaccines against EBOLA infections. The project aims to evaluate the immunogenicity of a family of original vaccines against EBOLA infection in a mouse model using a wide range of techniques (flow cytometry and gene expression profiling at single cell level, functional assays). The objectives are to dissect the nature and persistence of tissue-associated antigen-specific T and B cells responses and to identify the inductive mechanisms involved in vaccine-induced B and T cell responses.


The successful postdoctoral candidate should have a strong background in immunology, expertise in animal handling and flow cytometry. Experience in molecular biology and bioinformatic analyses will be an advantage. Written and spoken English communication skills, strong self-motivation, the ability to work both independently and collaboratively are expected.


Please send applications (full CV and the name of 2-3 referees in a single pdf document) and requests for further information by email to Fabienne Anjuère ([email protected])


Starting date: September to December 2018

Offre précédente picto prev
Offre suivante picto next